Interferon-α2a and 13-cis-retinoic acid with radiation treatment for high-grade glioma

Neuro-Oncology

Volumn 3, Issue 1, 2001, Pages 35-41

  Dillman, Robert O ^a   Shea, W Michael ^a   Tai, D Fritz ^b   Mahdavi, Khosrow ^a   Barth, Neil M ^a   Kharkar, Bharati R ^b   Poor, Marshall M ^b   Church, Curtis K ^c   DePriest, Carol ^c  

^a HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

^b Bloomington Hospital   (United States)

^c Ctrl Off Cancer Biotherapy Res G   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT; BIOLOGICAL RESPONSE MODIFIER; ISOTRETINOIN; PHENYTOIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BRAIN TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CRANIOTOMY; DRUG CONTRAINDICATION; DRUG ERUPTION; FEMALE; GLIOBLASTOMA; HUMAN; HYPERTRIGLYCERIDEMIA; LIFE TABLE; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; RADIATION INJURY; RADIOISOTOPE THERAPY; SURVIVAL; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOLOGICAL RESPONSE MODIFIERS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CRANIOTOMY; DRUG ERUPTIONS; FEMALE; GLIOBLASTOMA; HUMANS; HYPERTRIGLYCERIDEMIA; INTERFERON ALFA-2A; ISOTRETINOIN; LIFE TABLES; MALE; MIDDLE AGED; PHENYTOIN; RADIATION INJURIES; RADIOISOTOPE TELETHERAPY; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 0035235308     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1522851700000363     Document Type: Article

References (29)

1. Black, P.M. (1991a) Brain tumors. Pt. 1. N. Engl. J. Med. 324, 1471-1476.
2. Black, P.M. (1991b) Brain tumors. Pt. 2. N. Engl. J. Med. 324, 1555-1564.
3. Bruner, J.M. (1994) Neuropathology of malignant gliomas. Semin. Oncol. 21, 126-138.
4. Cooper, J.J., Borok, T.L., Ransohoff, J., and Carella, R.J. (1982) Malignant glioma: Results of combined modality therapy. JAMA 248, 62-65.
5. Daumas-Duport, C., Scheithauer, B., O'Fallon, J., and Kelly, P. (1988) Grading of astrocytomas: A simple and reproducible method. Cancer 62, 2152-2165.
6. Delattre, J.Y., Safai, B., and Posner, J.B. (1988) Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 38, 194-198.
7. Dillman, R.O., Wiemann, M., Oldham, R.K., Soori, G., Bury, M., Hafer, R., Church, C., and DePreist, C. (1995) Interferon α-2a and external beam radiotherapy in the initial management of patients with glioma: A pilot study of the National Biotherapy Study Group. Cancer Biother. 10, 265-271.
8. Dillman, R.O., Soori, G., Tai, D.F., Honeycutt, P., DePriest, C., and Church, C. (1997) Interferon α-2a (IFN) and cis-retinoic acid (CRA) for the treatment of squamous cell carcinoma (SCC): A preliminary report. J. Immunother. 20, 404. (Abstract)
9. Fine, H.A., Dear, K.B.G., Loeffler, J.S., Black, P.M., and Canellos, G.P. (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71, 2585-2597.
10. Green, S.B., Byar, D.P., Walker, M.D., Pistenmaa, D.A., Alexander, E., Jr., Batzdorf, U., Brooks, W.H., Hunt, W.E., Mealy, J., Jr., Odom, G.L., Paoletti, P., Ransohoff, J., II, Robertson, J.T., Selker, R.G., Shapiro, W.R., Smith, K.R, Jr., Wilson, C.B., and Strike, T.A. (1983) Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 67, 121-132.
11. Kaplan, E.L., and Meier, P. (1958) Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc 53, 457-481.
12. Kelley, K.A., Kirkwood, J.M., and Kapp, D.S. (1984) Glioblastoma multiforme: Pathology, natural history, and treatment Cancer Treat Rev. 11, 1-26.
13. Laws, E.R., Jr., and Thapar, K. (1993) Brain tumors. CA Cancer J. Clin. 43, 263-271.
14. Leibel, S.A., Scott, C.B., and Loeffler, J.S. (1994) Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin. Oncol. 21, 198-219.
15. Loeffler, J.S., Alexander, E., III, Shea, W.M., Wen, P.Y., Fine, H.A., Kooy, H.M., and Black, P.M. (1992) Radiosurgery as part of the initial management of patients with malignant gliomas. J. Clin. Oncol. 10, 1379-1385.
16. Lesser, G.J., and Grossman, S. (1994) The chemotherapy of high-grade astrocytomas. Semin. Oncol. 21, 220-235.
17. Lippman, S.M., Parkinson, D.R., Itri, L.M., Weber, R.S., Schantz, S.P., Ota, D.M., Schusterman, M.A., Krakoff, I.H., Gutterman, J.U., and Hong, W.K. (1992) 13-cis-retinoic acid and interferon α-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J. Natl. Cancer Inst. 84, 235-241.
18. Lippman, S.M., Kavanagh, J.J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W.K., Massimini, G., Holdener, E.E., and Krakoff, I.H. (1993) 13-cis-retinoic acid plus interferon-α 2a in locally advanced squamous cell carcinoma of the cervix. J. Natl. Cancer Inst. 85, 499-500.
19. Malone, C., Schiltz, P.M., Nayak, S.K., Shea, M.W., and Dillman, R.O. (1999) Combination interferon-α2a and 13-cis-retinoic acid enhances radiosensitization of human malignant glioma cells in vitro. Clin. Cancer Res. 5, 417-423.
20. McVie, J.G. (1993) The therapeutic challenge of gliomas. Eur. J. Cancer 29A, 936-939.
21. Morantz, R.A., and Wara, W.M. (1995) Gamma knife radiosurgery in the treatment of brain tumors. Cancer Control 2, 300-307.
22. Phillips, G.L., Wolff, S.N., Fay, J.W., Herzig, R.H., Lazarus, H.M., Schold, C., and Herzig, G.P. (1986) Intensive 1,3-bis(2-chlorethyl)-1-nitrosourea [BCNU] monochemotherapy and autologous marrow transplantation for malignant glioma. J. Clin. Oncol. 4, 639-645.
23. Ricci, P.E., Karis, J.P., Heiserman, J.E., Fram, E.K., Bice, A.N., and Drayer, B.P. (1998) Differentiating recurrent tumor from radiation necrosis: Time for re-evaluation of positron emission tomography? AJNR Am. J. Neuroradiol. 19, 407-413.
24. Schwartz, R.B., Holman, B.L., Polak, J.F., Garada, B.M., Schwartz, M.S., Folkerth, R., Carvalho, P.A., Loeffler, J.S., Shrieve, D.C., Black, P.M., and Alexander, E., III (1998) Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: Association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J. Neurosurg. 89, 60-68.
25. Shrieve, D.C., Alexander, E., III, Black, P.M., Wen, P.Y., Fine, H.A., Kooy, H.M., and Loeffler, J.S. (1999) Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome. J. Neurosurg. 90, 72-77.
26. Trotti, A., Byhardt, R., Stetz, J., Gwede, C., Corn, B., Fu, K., Gunderson, L., McCormick, B., Morrisintegral, M., Rich, T., Shipley, W., and Curran, W. (2000) Common toxicity criteria: Version 2.0 an Improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int. J. Radiat. Oncol. Phys. 47, 13-47.
27. Weller, M., and Fontana, A. (1995) The failure of current immunotherapy for malignant glioma. Tumor derived TGF-beta, T-cell apoptosis, and the Immune privilege of the brain. Brain Res. Brain Res. Rev. 21, 128-151.
28. Werner-Wasik, M., Scott, C.B., Nelson, D.F., Gaspar, L.E., Murray, K.J., Fischbach, J.A., Nelson, J.S., Weinstein, A.S., and Curran, W.J., Jr. (1996) Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation Therapy Oncology Group Study 83-02. Cancer 77, 1535-1543.
29. Yung, W.K.A., Levin, V.A., Kyritsis, A., Jaeckle, K., Winn, R., Baidas, S., Martuza, R., and Vaickus, L. (1995) Phase II study of rhIFN-β +/-CRA in recurrent gliomas. Proc. Am. Soc Clin. Oncol. 14, 148. (Abstract)